Patents Assigned to Quest Diagnostics Investments LLC
-
Publication number: 20190100804Abstract: The present invention relates to methods for simultaneously determining the presence or absence of mutations, deletions, duplications and single nucleotide polymorphisms in a cystic fibrosis transmembrane regulator (CFTR) nucleic acid. Oligonucleotide primers and kits used to amplify regions of a CFTR nucleic acid for high throughput, massively parallel sequencing and methods of determining an individual's cystic fibrosis status are also disclosed.Type: ApplicationFiled: October 12, 2018Publication date: April 4, 2019Applicant: QUEST DIAGNOSTICS INVESTMENTS LLCInventor: Steven Patrick Rivera
-
Publication number: 20190100807Abstract: The invention disclosed herein is based on the identification of novel mutations in the JAK2 gene and JAK2 protein. The invention provides compositions and methods useful for diagnosing hematopoietic diseases including, for example, myeloproliferative diseases. The invention also provides compositions and methods useful for determining a prognosis of an individual diagnosed as having a hematopoietic disease.Type: ApplicationFiled: October 12, 2018Publication date: April 4, 2019Applicant: Quest Diagnostics Investments LLCInventors: Maher Albitar, Wanlong Ma
-
Publication number: 20190093176Abstract: Described herein are methods, compositions and kits directed to the detection of gene dysregulations such as those arising from gene fusions and/or chromosomal abnormalities, e.g., translocations, insertions, inversions and deletions. Samples containing dysregulated gene(s) of interest may show independent expression patterns for the 5? and 3? regions of the gene. The methods, compositions and kits are useful for detecting mutations that cause the differential expression of a 5? portion of a target gene relative to the 3? region of the target gene.Type: ApplicationFiled: October 5, 2018Publication date: March 28, 2019Applicant: Quest Diagnostics Investments LLCInventors: Heather R. Sanders, Maher Albitar, Aurelia Meloni-Ehrig
-
Publication number: 20190079070Abstract: Methods are described for diagnosing or prognosing insulin resistance in diabetic and pre-diabetic patients, the method comprising determining the amount of insulin and C-peptide in a sample. Provided herein are mass spectrometric methods for detecting and quantifying insulin and C-peptide in a biological sample utilizing enrichment and/or purification methods coupled with tandem mass spectrometric or high resolution/high accuracy mass spectrometric techniques.Type: ApplicationFiled: March 30, 2018Publication date: March 14, 2019Applicant: Quest Diagnostics Investments LLCInventors: Dov Shiffman, Carmen Tong, James J. Devlin, Michael J. McPhaul
-
Patent number: 10226120Abstract: A work space apparatus for performing scientific analysis having a plurality of modules coupled to an upper region of a desk surface and a top surface coupled to and vertically above the plurality of modules. Each of the plurality of modules has a width defined by a first sidewall and second sidewall and a height that is adjustable.Type: GrantFiled: August 19, 2016Date of Patent: March 12, 2019Assignee: QUEST DIAGNOSTICS INVESTMENTS LLCInventor: Laura Chau
-
Publication number: 20190062844Abstract: Provided herein are methods for miRNA profiling for the diagnosis, prognosis, and management of melanoma and differentiation of melanoma from nevi.Type: ApplicationFiled: August 20, 2018Publication date: February 28, 2019Applicant: Quest Diagnostics Investments LLCInventors: Kevin Qu, Anthony Sferruzza, Ke Zhang, Yan Liu, Renius Owen
-
Publication number: 20190062850Abstract: Provided herein are methods for determining the presence or absence of an enteroviruses and parechoviruses in a biological sample. The methods involve identifying the presence or absence of a target nucleic acids from the viruses using direct amplification from a biological sample without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids. Also provided are methods of diagnosis using the methods provided and compositions and kits for the practice of the methods.Type: ApplicationFiled: September 7, 2018Publication date: February 28, 2019Applicant: QUEST DIAGNOSTICS INVESTMENTS LLCInventors: Peter Lee, Lakshmi Nair, Albert Castro, Maria Vestal, Michelle Tabb
-
Publication number: 20190062726Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: ApplicationFiled: August 31, 2018Publication date: February 28, 2019Applicant: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li
-
Publication number: 20190064170Abstract: The present invention provides methods of classifying cluster of differentiation (CD) marker phenotype for hematopoietic cancer cells using multiple circulating cell-free CD markers in bodily fluid. In other aspects, treatment and disease progression of particular hematopoietic cancers can be monitored by measuring the levels of CD and other markers in bodily fluids of a patient.Type: ApplicationFiled: August 31, 2018Publication date: February 28, 2019Applicant: Quest Diagnostics Investments LLCInventor: Maher Albitar
-
Patent number: 10140418Abstract: A system (100) for classifying a biological test sample, including a database (112) populated with reference expression data. The reference expression data includes expression levels of a plurality of molecules (polynucleotides or polypeptides), including a set of marker molecules, in a plurality of reference samples. Each reference sample has a pre-assigned value for each of one or more clinically significant variables. The system includes at least one processor (110) and at least one storage medium containing program instructions for execution by said processor (110). The program instructions cause the processor to accept (122) input expression data including a test vector of expression levels of the marker molecules in the biological test sample; and pass the input expression data to one or more analysis programs (130a, 130b, 135).Type: GrantFiled: November 20, 2014Date of Patent: November 27, 2018Assignee: Quest Diagnostics Investments LLCInventor: Ryan L. Van Laar
-
Publication number: 20180135128Abstract: The present disclosure provides methods for determining whether a patient exhibiting cystic fibrosis symptoms, or a patient at risk for cystic fibrosis, will benefit from treatment with one or more anti-cystic fibrosis therapeutic agents. These methods are based on detecting hereditary cystic fibrosis related mutations in small-volume dried biological fluid samples that are collected using a volumetric absorptive microsampling device. Kits for use in practicing the methods are also provided.Type: ApplicationFiled: November 13, 2017Publication date: May 17, 2018Applicant: Quest Diagnostics Investments LLCInventors: Heather Sanders, Nigel J. Clarke
-
Publication number: 20180135135Abstract: The present disclosure provides rapid and non-invasive methods for determining whether a patient exhibiting cancer symptoms, or at risk for hereditary cancers such as breast cancer, ovarian cancer, colon cancer, or skin cancer, will benefit from treatment with one or more therapeutic agents. These methods are based on detecting hereditary cancer-related mutations in small-volume dried biological fluid samples that are collected using a volumetric absorptive microsampling device (e.g., MITRA Tip). Kits for use in practicing the methods are also provided.Type: ApplicationFiled: November 13, 2017Publication date: May 17, 2018Applicant: Quest Diagnostics Investments LLCInventors: Heather Sanders, Nigel J. Clarke
-
Publication number: 20180136211Abstract: The present disclosure provides rapid and non-invasive methods for determining whether a patient will benefit from treatment with therapeutic agents that inhibit Hepatitis C virus (HCV). These methods are based on detecting HCV RNA and/or anti-HCV antibodies in small-volume dried biological fluid samples that are collected using a microsampling device. Kits for use in practicing the methods are also provided.Type: ApplicationFiled: November 13, 2017Publication date: May 17, 2018Applicant: Quest Diagnostics Investments LLCInventors: Amy Rogers, John A. Leake, Nigel J. Clarke, Russell E. Baumann
-
Publication number: 20180094301Abstract: The present invention provides methods and compositions for determining prognosis in individual with cancer, in particular endometrial cancer. The present invention also provides methods of developing and using predictive models that are useful for determining prognosis of endometrial cancer and other similar diseases. The present invention further provides methods for determining microsatellite status using next generation sequencing.Type: ApplicationFiled: February 5, 2016Publication date: April 5, 2018Applicant: Quest Diagnostics Investments LLCInventors: Yongbao WANG, Kevin J. ARVAI, Daniel JONES
-
Publication number: 20170089917Abstract: Provided are methods for the detection or quantitation of amyloid beta. In a particular aspect, provided herein are methods for detecting amyloid beta or fragments thereof by mass spectrometry. In another aspect, provided herein are methods for determining the ratio of amyloid beta 42 (A?42) to amyloid beta 40 (A?40). In another aspect, provided herein are methods for diagnosis or prognosis of Alzheimer's disease or dementia.Type: ApplicationFiled: September 27, 2016Publication date: March 30, 2017Applicant: Quest Diagnostics Investments LLCInventors: Diana Tran, Darren Weber, Nigel Clarke
-
Publication number: 20170049225Abstract: A work space apparatus for performing scientific analysis having a plurality of modules coupled to an upper region of a desk surface and a top surface coupled to and vertically above the plurality of modules. Each of the plurality of modules has a width defined by a first sidewall and second sidewall and a height that is adjustable.Type: ApplicationFiled: August 19, 2016Publication date: February 23, 2017Applicant: Quest Diagnostics Investments LLCInventor: Laura Chau
-
Publication number: 20160349221Abstract: Mass spectrometric methods are described for determining the amount of analyte in a sample collected by a microsampling device. Provided herein are methods directed to quantitating the amount of an analyte in a sample by extracting an analyte from a sample collected by a microsampling device, purifying the sample by liquid chromatography, ionizing the analyte to generate one or more ions detectable by mass spectrometry; and determining the amount of the one or more ions by mass spectrometry. The amount of analyte in the sample is related to the amount of analyte in the patient.Type: ApplicationFiled: May 27, 2016Publication date: December 1, 2016Applicant: Quest Diagnostics Investments LLCInventors: Scott Goldman, Mildred Goldman, Leslie Edinboro, Diana Tran, Julia Addiss, Darren Weber, Porus Mistry, Nigel Clarke
-
Publication number: 20160282328Abstract: Methods are described for determining the amount of insulin in a sample. Provided herein are mass spectrometric methods for detecting and quantifying insulin and C-peptide in a biological sample utilizing enrichment and/or purification methods coupled with tandem mass spectrometric or high resolution/high accuracy mass spectrometric techniques. Also provided herein are mass spectrometric methods for detecting and quantifying insulin and b-chain in a biological sample utilizing enrichment and/or purification methods coupled with tandem mass spectrometric or high resolution/high accuracy mass spectrometric techniques.Type: ApplicationFiled: March 2, 2016Publication date: September 29, 2016Applicant: Quest Diagnostics Investments LLCInventors: Stephen W. TAYLOR, Michael McPHAUL, Richard E. REITZ, Zhaohui CHEN, Nigel CLARKE